Literature DB >> 12618894

Vitamin K(2) selectively induced apoptosis in ovarian TYK-nu and pancreatic MIA PaCa-2 cells out of eight solid tumor cell lines through a mechanism different from geranylgeraniol.

Toshiko Shibayama-Imazu1, Shizuka Sakairi, Akiko Watanabe, Toshihiro Aiuchi, Shigeo Nakajo, Kazuyasu Nakaya.   

Abstract

PURPOSE: In this study, we examined the effects of vitamin K(2) (menaquinone 4), which has a geranylgeranyl side chain, on various lines of cells derived from human solid tumors and compared them with the effects of geranylgeraniol (GGO).
METHODS: Cell proliferation was determined with 3'-[1-[(phenylamino)carbonyl]-3,4-tetrazolium- bis (4-methoxy-6-nitro) benzene-sulfonic acid hydrate (XTT), and the induction of apoptosis was analyzed by TUNEL staining and flow cytometry as well as by measurement of DNA fragmentation, released nucleosomes and caspase-3 activity. Levels of Bcl-2, Bax and cytochrome c were determined by immunoblotting.
RESULTS: GGO inhibited the growth of all eight cell lines derived from solid tumors, while vitamin K(2) selectively inhibited the proliferation of ovarian TYK-nu and pancreatic MIA PaCa-2 cancer cells, inducing apoptosis in both cell lines. Far more time was required for the induction of apoptosis in these two cell lines by vitamin K(2) than by GGO. Apoptotic signals induced in TYK-nu cells during the first 2 days that followed the addition of vitamin K(2) to the culture medium were reversible, but these signals became irreversible after 3 days of treatment with vitamin K(2). The induction of apoptosis in TYK-nu cells by vitamin K(2) was inhibited by cycloheximide and also by starvation at a low concentration of serum. Neither cycloheximide nor starvation had any effect on the induction of apoptosis by GGO. Cytochrome c was released simultaneously with the initiation of apoptosis on treatment of TYK-nu cells with vitamin K(2) or GGO. However, GGO induced the release of cytochrome c from isolated mitochondria, while vitamin K(2) did not. The amount of Bcl-2 in TYK-nu cells was reduced by vitamin K(2), but not by GGO.
CONCLUSIONS: In contrast to GGO, vitamin K(2) induced apoptosis selectively in pancreatic MIA-PaCa 2 and ovarian TYK-nu cancer cells. It is suggested that de novo protein synthesis might be necessary for induction of apoptosis by vitamin K(2) but not by GGO, and thus, that vitamin K(2) and GGO might induce apoptosis by different mechanisms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12618894     DOI: 10.1007/s00432-002-0393-7

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  10 in total

1.  Geranylgeraniol suppresses the viability of human DU145 prostate carcinoma cells and the level of HMG CoA reductase.

Authors:  Nicolle V Fernandes; Hoda Yeganehjoo; Rajasekhar Katuru; Russell A DeBose-Boyd; Lindsey L Morris; Renee Michon; Zhi-Ling Yu; Huanbiao Mo
Journal:  Exp Biol Med (Maywood)       Date:  2013-09-04

2.  Vitamin K enhancement of sorafenib-mediated HCC cell growth inhibition in vitro and in vivo.

Authors:  Gang Wei; Meifang Wang; Terry Hyslop; Ziqiu Wang; Brian I Carr
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

3.  Sorafenib combined vitamin K induces apoptosis in human pancreatic cancer cell lines through RAF/MEK/ERK and c-Jun NH2-terminal kinase pathways.

Authors:  Gang Wei; Meifang Wang; Brian I Carr
Journal:  J Cell Physiol       Date:  2010-07       Impact factor: 6.384

4.  Induction of apoptosis in PA-1 ovarian cancer cells by vitamin K2 is associated with an increase in the level of TR3/Nur77 and its accumulation in mitochondria and nuclei.

Authors:  Toshiko Sibayama-Imazu; Yukari Fujisawa; Yutaka Masuda; Toshihiro Aiuchi; Shigeo Nakajo; Hiroyuki Itabe; Kazuyasu Nakaya
Journal:  J Cancer Res Clin Oncol       Date:  2008-01-17       Impact factor: 4.553

5.  Oil A induces apoptosis of pancreatic cancer cells via caspase activation, redistribution of cell cycle and GADD expression.

Authors:  Mi-Lian Dong; Yue-Chun Zhu; John V Hopkins
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

6.  Growth inhibitory actions of prothrombin on normal hepatocytes: influence of matrix.

Authors:  Brian I Carr; Siddhartha Kar; Meifang Wang; Ziqiu Wang
Journal:  Cell Biol Int       Date:  2007-03-19       Impact factor: 3.612

Review 7.  Vitamins in pancreatic cancer: a review of underlying mechanisms and future applications.

Authors:  Ashley H Davis-Yadley; Mokenge P Malafa
Journal:  Adv Nutr       Date:  2015-11-13       Impact factor: 8.701

8.  Strong enhancement by IGF1-R antagonists of hepatocellular carcinoma cell migration inhibition by Sorafenib and/or vitamin K1.

Authors:  Rosalba D'Alessandro; Maria Grazia Refolo; Catia Lippolis; Nicola Carella; Caterina Messa; Aldo Cavallini; Brian Irving Carr
Journal:  Cell Oncol (Dordr)       Date:  2018-02-22       Impact factor: 6.730

9.  IGF-1R tyrosine kinase inhibitors and Vitamin K1 enhance the antitumor effects of Regorafenib in HCC cell lines.

Authors:  Maria Grazia Refolo; Rosalba D'Alessandro; Catia Lippolis; Nicola Carella; Aldo Cavallini; Caterina Messa; Brian Irving Carr
Journal:  Oncotarget       Date:  2017-09-30

Review 10.  Role of Vitamin K in Selected Malignant Neoplasms in Women.

Authors:  Anna Markowska; Michał Antoszczak; Janina Markowska; Adam Huczyński
Journal:  Nutrients       Date:  2022-08-18       Impact factor: 6.706

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.